Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: October 6, 2004
Last updated: June 21, 2013
Last verified: November 2005
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2005
  Estimated Primary Completion Date: No date given